⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8012124 | 0.71 | — | — | |
| Oxalic Acid SCHEMBL27460722 | 0.65 | CA1 (0.36) | — | |
| Water SCHEMBL8848944 | 0.65 | — | — | |
| SCHEMBL37136 | 0.65 | — | — | |
| SCHEMBL7195077 | 0.65 | ALDH1A1 (0.32) | — | |
| SCHEMBL4376330 | 0.65 | — | — | |
| SCHEMBL7195083 | 0.65 | ALDH1A1 (0.32) | — | |
| Oxalic Acid SCHEMBL9774270 | 0.64 | CA1 (0.44) | — | |
| Oxalic Acid SCHEMBL8108613 | 0.64 | CA1 (0.44) | — | |
| Oxalic Acid SCHEMBL20995295 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9181199-B2 | Uracil derivatives and use thereof | RESPROTECT GMBH (DE) | 2015-11-10 | — | — | US | claimed |
| US-20110166096-A1 | URACIL DERIVATIVES AND USE THEREOF | RESPROTECT GMBH (DE) | 2011-07-07 | — | — | US | claimed |
| EP-2303848-A2 | URACIL DERIVATIVES AND USE THEREOF | Resprotect GmbH (DE) | 2011-04-06 | — | — | EP | claimed |
| US-7700655-B2 | Antiallergic agents | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2010-04-20 | — | — | US | claimed |
| WO-2009156182-A2 | URACIL DERIVATIVES AND USE THEREOF | RESPROTECT GMBH (DE) | 2009-12-30 | — | — | WO | claimed |
| US-20080311074-A1 | Inhibitors against activation of NF-kappaB | INSTITUTE OF MEDICAL MOLECULAR DESIGN INC. (JP) | 2008-12-18 | — | — | US | claimed |
| US-20080234233-A1 | MEDICAMENT FOR TREATMENT OF NEURODEGENERATIVE DISEASES | INSTITUTE OF MEDICINAL MOLECULAR DESIGN INC. (JP) | 2008-09-25 | — | — | US | claimed |
| US-20080090779-A1 | ANTIALLERGIC AGENTS | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2008-04-17 | — | — | US | claimed |
| US-20070185059-A1 | Antiallergic agents | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2007-08-09 | — | — | US | claimed |
| US-20070185110-A1 | Antiallergic agents | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2007-08-09 | — | — | US | claimed |
| US-20070042997-A1 | Medicament for treatment of dermal pigmentation | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2007-02-22 | — | — | US | claimed |
| EP-1649852-A1 | CHROMATOSIS REMEDIES | Institute of Medicinal Molecular Design, Inc. (JP) | 2006-04-26 | — | — | EP | claimed |
| CN-106463273-B | Photo-electric conversion element, dye-sensitized solar cell, metal complex dye, pigment solution and terpyridyl compounds or its carboxylate | 富士胶片株式会社 | 2019-01-15 | — | — | CN | disclosed |
| CN-106463274-B | Photoelectric conversion element, dye-sensitized solar cell, metal complex dye, dye solution, and terpyridine compound or ester thereof | 富士胶片株式会社 | 2018-09-07 | — | — | CN | disclosed |
| CN-105874033-A | Optical wavelength conversion element containing ionic liquid and article comprising same | 日本化药株式会社 | 2016-08-17 | — | — | CN | disclosed |
| US-9181199-B2 | Uracil derivatives and use thereof | RESPROTECT GMBH (DE) | 2015-11-10 | — | — | US | disclosed |
| EP-1510207-A1 | THERAPEUTIC DRUG FOR DIABETES | Institute of Medicinal Molecular Design, Inc. (JP) | 2005-03-02 | — | — | EP | disclosed |
| EP-1510210-A1 | IMMUNITY-RELATED PROTEIN KINASE INHIBITORS | Institute of Medicinal Molecular Design, Inc. (JP) | 2005-03-02 | — | — | EP | disclosed |
| US-20040259877-A1 | Inhibitors against the production and release of inflammatory cytokines | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2004-12-23 | — | — | US | disclosed |
| EP-1352650-A1 | INHIBITORS AGAINST THE PRODUCTION AND RELEASE OF INFLAMMATORY CYTOKINES | Institute of Medicinal Molecular Design, Inc. (JP) | 2003-10-15 | — | — | EP | disclosed |